(Reuters) – The European Union’s health regulator on Thursday approved Sanofi’s COVID-19 vaccine tailored to the Beta variant of the coronavirus as a booster for adults who have previously been administered mRNA or adenoviral vector shots.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)
